EEG, ERPs, and EROs in patients with cognitive deficits due to progressive neurodegenerative diseases: The dark side of the precision medicine

Basit Öğe Kaydı
dc.authorid0000-0002-0860-0524
dc.contributor.authorBabiloni, Claudio
dc.contributor.authorGüntekin, Bahar
dc.date.accessioned2023-07-14T06:33:31Z
dc.date.available2023-07-14T06:33:31Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Rektörlük, Sağlık Bilim ve Teknolojileri Araştırma Enstitüsü
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Biyofizik Ana Bilim Dalı
dc.description.abstractMany millions of patients worldwide live with age-related progressive neurodegenerative diseases such as Alzheimer's, Parkinson's, Lewy body, and others belonging to severe cognitive deficits and disabilities in the activities of daily living (i.e., dementia) until death after a disease course of 10–15 years (Lemstra et al., 2017; Teipel et al., 2022). Indeed, no effective disease-blocking therapy is available to date. These diseases are caused by insufficient homeostasis of potentially neurotoxic proteins (e.g., amyloid, phospho tau, alpha-synuclein, TDP-43, light neurofibrillary chains) that progressively accumulate in the brain, affecting synaptic transmission and the generation and conduction of action potentials until neural loss (Lemstra et al., 2017; Jack Jr et al., 2018; Scott et al., 2022; Teipel et al., 2022).
dc.description.sponsorshipAlzheimer's Association International Society to Advance Alzheimer's Research and Treatment ; Global Brain Consortium ; ISTAART ; Alzheimer's Associationen_US
dc.identifier.citationBabiloni, C. ve Güntekin, B. (2023). EEG, ERPs, and EROs in patients with cognitive deficits due to progressive neurodegenerative diseases: The dark side of the precision medicine. International Journal of Psychophysiology, 190, 56-59. https://doi.org/10.1016/j.ijpsycho.2023.06.005
dc.identifier.doi10.1016/j.ijpsycho.2023.06.005
dc.identifier.endpage59
dc.identifier.issn0167-8760
dc.identifier.issn1872-7697
dc.identifier.pmid37302661
dc.identifier.scopus2-s2.0-85163220957
dc.identifier.scopusqualityQ2
dc.identifier.startpage56
dc.identifier.urihttps://doi.org/10.1016/j.ijpsycho.2023.06.005
dc.identifier.urihttps://hdl.handle.net/20.500.12511/11196
dc.identifier.volume190
dc.identifier.wos001030358100001en_US
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorGüntekin, Bahar
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofInternational Journal of Psychophysiologyen_US
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectPrecision Medicine
dc.subjectNeurodegenerative Diseases
dc.subjectCognitive Deficits
dc.subjectEROs
dc.subjectEEG
dc.subjectERPs
dc.titleEEG, ERPs, and EROs in patients with cognitive deficits due to progressive neurodegenerative diseases: The dark side of the precision medicine
dc.typeEditorial

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Guntekin-Bahar-2023.pdf
Boyut:
1.16 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Diğer Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu